Extracorporeal Membrane Oxygenation to Support COVID-19 Patients: A Propensity-Matched Cohort Study.

Bjorn Stessel Maayeen Bin SaadLotte UllrickLaurien GeebelenJeroen LehaenPhilippe Jr TimmermansMichiel Van TornoutIna Callebaut Jeroen Vandenbrande Jasperina Dubois

Published in: Critical care research and practice (2023)

ECMO therapy may be associated with an up to a three-fold increase in ICU mortality and 3-month mortality compared to MVA despite the facilitation of lung-protective ventilation settings in mechanically ventilated COVID-19 patients. We cannot confirm the positive results of the first propensity-matched cohort study on this topic. This trial is registered with NCT05158816.

Keyphrases

extracorporeal membrane oxygenation
acute respiratory distress syndrome
mechanical ventilation
respiratory failure
sars cov
intensive care unit
cardiovascular events
risk factors
phase iii
cardiovascular disease
phase ii
stem cells
mesenchymal stem cells
bone marrow
cell therapy
placebo controlled